Lifshitz & Miller LLP Announces Investigation of Arlo Technologies, Inc., Alkermes Public Limited Company, Lexicon Pharmaceuticals, Inc., BSB Bancorp, Inc., Markel Corporation, Natural Health Trends C

Lifshitz & Miller LLP Announces Investigation of Arlo Technologies, Inc., Alkermes Public Limited Company, Lexicon Pharmaceuticals, Inc., BSB Bancorp, Inc., Markel Corporation, Natural Health Trends Corp., and Nova Lifestyle, Inc.

PR Newswire

NEW YORK, Feb. 14, 2019 /PRNewswire/ --

Arlo Technologies, Inc. (ARLO)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with the announcement that shipment of Arlo's Ultra camera would be delayed due to "a quality issue with the battery from one of its suppliers."

If you are an Arlo investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Alkermes Public Limited Company (ALKS)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations that ALKS 5461 New Drug Application prospects were misrepresented.

If you are an Alkermes investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

BSB Bancorp, Inc. (BLMT)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties in connection with the sale of BSB to People's United Financial, Inc. for approximate value of $32.42 per share.

If you are a BSB investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Lexicon Pharmaceuticals, Inc. (LXRX)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with the announcement that an FDA committee voted against the Zynquista drug product, stating that its benefits did not outweigh the risks for approval.

If you are a Lexicon investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Markel Corporation (MKL)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with the announcement that the Company was responding to inquiries by US and Bermuda authorities into loss reserves recorded in late 2017 and early 2018.

If you are a Markel investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Natural Health Trends Corp. (NHTC)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations that NHTC operated a pyramid scheme in China.

If you are a Natural Health Trends investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Nova Lifestyle, Inc. (NVFY)

Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations of fictitious sales at Nova, specifically "booked sales of over $50 million in recent years to two companies that either have been dissolved or do not exist. . . ."

If you are a Nova investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING. © 2018 Lifshitz & Miller LLP.  The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone:  516-493-9780
Facsimile: 516-280-7376
Email: [email protected]

Cision View original content:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-announces-investigation-of-arlo-technologies-inc-alkermes-public-limited-company-lexicon-pharmaceuticals-inc-bsb-bancorp-inc-markel-corporation-natural-health-trends-corp-and-nova-lifestyle-inc-300796129.html

SOURCE Lifshitz & Miller Law Firm

Copyright CNW Group 2019